Partner
King & Spalding LLP
Columns
| Title | Category | Published |
|---|---|---|
| Mifepristone debate could jeopardize access to many other FDA-approved drugs | Government, Health Care & Hospital Law | May 12, 2023 |
| What's the right remedy for a constitutional structural wrong? | Administrative/Regulatory, Constitutional Law, Government, U.S. Supreme Court | Dec. 21, 2020 |
| Tea leaves and the CFPB | Constitutional Law, Government, U.S. Supreme Court | Jul. 13, 2020 |
| CFPB survives, but for how long? | Administrative/Regulatory, Constitutional Law, Government, U.S. Supreme Court | May 15, 2019 |
| Judge Brett Kavanaugh and the administrative state | Administrative/Regulatory, Constitutional Law, U.S. Supreme Court | Sep. 26, 2018 |
| Title | Category | Published |
|---|---|---|
| Mifepristone debate could jeopardize access to many other FDA-approved drugs | Government, Health Care & Hospital Law | May 12, 2023 |
| What's the right remedy for a constitutional structural wrong? | Administrative/Regulatory, Constitutional Law, Government, U.S. Supreme Court | Dec. 21, 2020 |
| Tea leaves and the CFPB | Constitutional Law, Government, U.S. Supreme Court | Jul. 13, 2020 |
| CFPB survives, but for how long? | Administrative/Regulatory, Constitutional Law, Government, U.S. Supreme Court | May 15, 2019 |
| Judge Brett Kavanaugh and the administrative state | Administrative/Regulatory, Constitutional Law, U.S. Supreme Court | Sep. 26, 2018 |